{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:02:42Z","timestamp":1774868562128,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.pbb.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T04:21:37Z","timestamp":1456978897000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["AC-3933, a benzodiazepine partial inverse agonist, improves memory performance in MK-801-induced amnesia mouse model"],"prefix":"10.1016","volume":"144","author":[{"given":"Takashi","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2016.03.001_bb0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbr.2009.06.005","article-title":"Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation","volume":"204","author":"Assini","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2016.03.001_bb0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2016.03.001_bb0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pbb.2016.03.001_bb0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/349156a0","article-title":"Long-term potentiation of NMDA receptor-mediated synaptic transmission in the hippocampus","volume":"349","author":"Bashir","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2016.03.001_bb0025","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","article-title":"Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity","volume":"12","author":"Chen","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2016.03.001_bb0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0306-4522(98)00163-8","article-title":"Neuroprotective concentrations of the N-methyl-d-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation","volume":"86","author":"Chen","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2016.03.001_bb0035","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.neuroscience.2006.05.006","article-title":"Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat","volume":"141","author":"Claustre","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2016.03.001_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1113\/jphysiol.1983.sp014478","article-title":"Excitatory amino acids in synaptic transmission in the Schaffer collateral\u2013commissural pathway of the rat hippocampus","volume":"334","author":"Collingridge","year":"1983","journal-title":"J. Physiol."},{"key":"10.1016\/j.pbb.2016.03.001_bb0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1527-3458.2007.00025.x","article-title":"Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects","volume":"13","author":"Evans","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.pbb.2016.03.001_bb0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.psych.48.1.649","article-title":"Central cholinergic systems and cognition","volume":"48","author":"Everitt","year":"1997","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.pbb.2016.03.001_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0006-8993(86)90611-6","article-title":"Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease","volume":"399","author":"Geddes","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2016.03.001_bb0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pbb.2016.03.001_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3940(87)90034-6","article-title":"Region-specific loss of glutamate innervation in Alzheimer's disease","volume":"73","author":"Hardy","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2016.03.001_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2014.10.015","article-title":"Procognitive effect of AC-3933 in aged mice, and synergistic effect of combination with donepezil in scopolamine-treated mice","volume":"745","author":"Hashimoto","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.03.001_bb0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neuroscience.2013.10.031","article-title":"Pharmacological properties of AC-3933, a novel benzodiazepine receptor partial inverse agonist","volume":"256","author":"Hashimoto","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2016.03.001_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuroscience.2014.01.063","article-title":"In vivo pharmacological characterization of AC-3933, a benzodiazepine receptor partial inverse agonist for the treatment of Alzheimer's disease","volume":"265","author":"Hatayama","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2016.03.001_bb0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neubiorev.2004.06.006","article-title":"The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory","volume":"28","author":"Hughes","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2016.03.001_bb0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0361-9230(87)90104-3","article-title":"Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes","volume":"19","author":"Jensen","year":"1987","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2016.03.001_bb0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jocn.2013.07.039","article-title":"Effects of vinpocetine and ozagrel on behavioral recovery of rats after global brain ischemia","volume":"21","author":"Jincai","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.pbb.2016.03.001_bb0100","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0968-0896(96)00137-X","article-title":"The rationale for E2020 as a potent acetylcholinesterase inhibitor","volume":"4","author":"Kawakami","year":"1996","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pbb.2016.03.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081244","article-title":"Hippocampal glutamate NMDA receptor loss tracks progression in Alzheimer's disease: quantitative autoradiography in postmortem human brain","volume":"8","author":"Kravitz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2016.03.001_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2016.03.001_bb0115","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.2174\/1381612819666140110115603","article-title":"NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease","volume":"20","author":"Lin","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbb.2016.03.001_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1567205053585846","article-title":"The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism","volume":"2","author":"Lipton","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pbb.2016.03.001_bb0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/JAD-140219","article-title":"Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?","volume":"42","author":"Macdonald","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pbb.2016.03.001_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(94)91397-8","article-title":"Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia","volume":"647","author":"Maurice","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2016.03.001_bb0135","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0091-3057(94)90235-6","article-title":"PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice","volume":"49","author":"Maurice","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2016.03.001_bb0140","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/319774a0","article-title":"Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5","volume":"319","author":"Morris","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2016.03.001_bb0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2013.08.013","article-title":"Dysfunctional synapse in Alzheimer's disease\u2014a focus on NMDA receptors","volume":"76","author":"Mota","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2016.03.001_bb0150","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1111\/j.1742-4658.2010.07719.x","article-title":"Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins","volume":"277","author":"Pham","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.pbb.2016.03.001_bb0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1037\/0735-7044.106.3.447","article-title":"Object exploration and reactions to spatial and nonspatial changes in hooded rats following damage to parietal cortex or hippocampal formation","volume":"106","author":"Save","year":"1992","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pbb.2016.03.001_bb0160","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00702-006-0579-2","article-title":"The significance of the cholinergic system in the brain during aging and in Alzheimer's disease","volume":"113","author":"Schliebs","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pbb.2016.03.001_bb0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0028-3908(97)00040-3","article-title":"Modulation of long-term potentiation in CA1 region of mouse hippocampal brain slices by GABAA receptor benzodiazepine site ligands","volume":"36","author":"Seabrook","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2016.03.001_bb0170","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/bph.12518","article-title":"GluN2C\/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice","volume":"171","author":"Suryavanshi","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.03.001_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.physbeh.2015.02.024","article-title":"Statins enhance cognitive performance in object location test in albino Swiss mice: involvement of beta-adrenoceptors","volume":"143","author":"Vandresen-Filho","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2016.03.001_bb0180","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/gps.1133","article-title":"Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials","volume":"19","author":"Whitehead","year":"2004","journal-title":"Int. J. Geriatr. Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716300247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716300247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T02:04:24Z","timestamp":1567649064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305716300247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":36,"alternative-id":["S0091305716300247"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2016.03.001","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AC-3933, a benzodiazepine partial inverse agonist, improves memory performance in MK-801-induced amnesia mouse model","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}